Naresh Bumma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma (NCT07657312) | Naresh Bumma | 2026-08-01 |
Track Naresh Bumma automatically
Every clearance here is in the API, with alerts when new ones post.